We finally emphasized the clinical significance of SIX‐1 in BC metastases by assessing the correlation between the SIX‐1 expression level and the clinicopathological characteristics, and showed that SIX‐1 was a promising diagnosis marker to predict poorly clinical outcomes of advanced BC. This evidence concerns the gene SIX1 and breast cancer.